Cervical Spondylosis Treatment Market, By Type of Treatment (Medications and Surgery), By Route of Administration, By Distribution Channel, By Geography

Description

The global cervical spondylosis treatment market size was valued at US$ 5.4 Billion in 2023 and is expected to reach US$ 7.9 Billion by 2030, growing at a Compound Annual Growth Rate (CAGR) of 5.6% from 2022 to 2030.

Report Coverage		Report Details
Base Year:	2022	Market Size in 2023:	US$ 5.4 Bn
Historical Data for:	2018 to 2021	Forecast Period:	2023 - 2030
Forecast Period 2023 to 2030 CAGR:	5.60%	2030 Value Projection:	US$ 7.9 Bn

Figure 1. Global Cervical Spondylosis Treatment Market Share (%), By Region, 2023

Cervical Spondylosis Treatment Market - IMG1

Cervical spondylosis is a type of degenerative disease that affects the neck. It is a general term for age-related wear and tear in the cervical spine (neck) that can lead to neck pain, neck stiffness, and other symptoms. Sometimes this condition is called arthritis or osteoarthritis of the neck. It is the natural wearing down of cartilage, disks, ligaments, and bones in the neck. It is very common and worsens with age. In many cases, no specific treatment is required. If symptoms occur, treatments include medication, corticosteroid injections, physiotherapy, and sometimes surgery.

Market Dynamics:

Rising burden of cervical spondylosis, increasing prevalence of neck and back pain, growing geriatric population, and the growing demand for safe & effective cervical spondylosis treatment around the globe are expected to propel the growth of the global cervical spondylosis treatment market.

For instance, cervical spondylosis is a very common cause of myelopathy in the elderly. It is the most common spine dysfunction in elderly people. It is very common and worsens with age. More than 85% of people older than the age of 60 are affected by cervical spondylosis. Thus, with the growing geriatric population and the rising burden of cervical spondylosis, the demand for safe and effective cervical spondylosis treatment is also increasing. As per the World Health Organization (WHO), by 2030, one in six people in the world will be aged 60 years or over, and the world's population of people aged 60 years and older will double (2.1 billion) by 2050.

Key Features of the Study:

This report provides an in-depth analysis of the global cervical spondylosis treatment market, and provides market size (US$ Billion) and Compound Annual Growth Rate (CAGR %) for the forecast period (2023-2030), considering 2022 as the base year
It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global cervical spondylosis treatment market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies
The key companies covered as a part of this study include Pfizer Inc., Abbott Laboratories, AstraZeneca Plc., Novartis AG, Merck & Co. Inc., Teva Pharmaceutical Industries Ltd., Amgen Inc., Bristol-Myers Squibb Company, Eli Lilly and Company, GlaxoSmithKline plc, Johnson & Johnson Services, Inc., Sanofi S.A., Stryker Corporation, Zimmer Biomet Holdings, Inc., and Medtronic plc
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global cervical spondylosis treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global cervical spondylosis treatment market

Detailed Segmentation:

By Type of Treatment:
- Medication
- Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
- Corticosteroids
- Muscle relaxants
- Antidepressants
- Others (Anti-seizure medications, etc.)
- Surgery
By Route of Administration:
- Oral
- Injection
- Topical
- Others (patches, etc.)
By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
Company Profiles:
- Pfizer Inc.
- Abbott Laboratories
- AstraZeneca Plc.
- Novartis AG
- Merck & Co. Inc.
- Teva Pharmaceutical Industries Ltd.
- Amgen Inc.
- Bristol-Myers Squibb Company
- Eli Lilly and Company
- GlaxoSmithKline plc
- Johnson & Johnson Services, Inc.
- Sanofi S.A.
- Stryker Corporation
- Zimmer Biomet Holdings, Inc.
- Medtronic plc

Product Code: CMI5710

Report Description
- Market Definition and Scope
Executive Summary
- Global Cervical Spondylosis Treatment Market, By Type of Treatment
- Global Cervical Spondylosis Treatment Market, By Route of Administration
- Global Cervical Spondylosis Treatment Market, By Distribution Channel
- Global Cervical Spondylosis Treatment Market, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Opportunities
Impact Analysis
Key Highlights
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario

4. Cervical Spondylosis Treatment Market - Impact of Coronavirus (COVID-19) Pandemic

COVID-19 Epidemiology
Supply Side and Demand Side Analysis
Economic Impact

5. Cervical Spondylosis Treatment Market, By Type of Treatment, 2018-2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019 - 2030
- Segment Trends
Medication
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
Corticosteroids
Muscle relaxants
Antidepressants
Others
Surgery
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)

6. Cervical Spondylosis Treatment Market, By Route of Administration, 2018-2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019 - 2030
- Segment Trends
Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
Injection
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
Topical
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)

7. Cervical Spondylosis Treatment Market, By Distribution Channel, 2018-2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019 - 2030
- Segment Trends
Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)

8. Cervical Spondylosis Treatment Market, By Region, 2018-2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019 - 2030
- Segment Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type of Treatment, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
U.S.
Canada
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type of Treatment, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type of Treatment, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
China
Japan
India
ASEAN
Australia
South Korea
Rest of Asia Pacific
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type of Treatment, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
Brazil
Mexico
Argentina
Rest of Latin America
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type of Treatment, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
GCC
Israel
Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type of Treatment, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2018-2030, (US$ Bn)
North Africa
Central Africa
South Africa

9. Competitive Landscape

Pfizer Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Abbott Laboratories
AstraZeneca Plc.
Novartis AG
Merck & Co. Inc.
Teva Pharmaceutical Industries Ltd.
Amgen Inc.
Bristol-Myers Squibb Company
Eli Lilly and Company
GlaxoSmithKline plc
Johnson & Johnson Services, Inc.
Sanofi S.A.
Stryker Corporation
Zimmer Biomet Holdings, Inc.
Medtronic plc

10. Section

Research Methodology
About us